Adaptive Biotechnologies stock price

어댑티브 바이오테크놀로지스NASDAQ:ADPT · Nasdaq · Healthcare · sector #20
$26.09-0.72%
2026-10-08 close
Loading chart…

Adaptive Biotechnologies's chart data is dated 2026-10-08. Recorded technical signals: Death cross. There are 20 published signal records.

Adaptive Biotechnologies last closed at $26.09 (-0.72%) on 2026-10-08. Signals today: Death cross. Listed on Nasdaq. Trailing 12 months PER is -64.4×. Its overall grade ranks 160 of 738 stocks in Healthcare.

About this company

Adaptive Biotechnologies last closed at $26.09 (-0.72%) on 2026-10-08. Signals today: Death cross. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A- · 160/738

Valuation grade A

Details →

Related stocks

  • IlluminaSupplier

    NGS(차세대 염기서열) 기반 면역레퍼토리 분석에 핵심 장비·플랫폼 공급사

  • PacBioSupplier

    고정밀 시퀀싱 데이터 확보에 활용되는 장비/플랫폼 공급사

  • 분자진단·연구용 시약과 장비를 공급하는 핵심 생명과학 인프라 기업

Details →

ETFs holding this stock

Franklin Genomic Advancements ETF · ROBO Global Healthcare Technology & Innovation ETF

Details →
About Adaptive Biotechnologies
What technical signals does Adaptive Biotechnologies (ADPT) have?
Adaptive Biotechnologies current technical signals: death cross (5_20, 0d ago).
Is Adaptive Biotechnologies a cup-and-handle pattern?
No. Adaptive Biotechnologies has no valid Cup signal right now.
What published figures are available for Adaptive Biotechnologies?
Market cap: $3.98B. Trailing 12 months PER: -64.4×. Latest quarter PBR: 27.31×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Turn what you saw on this name into a strategy

Ask Q about Adaptive Biotechnologies, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Adaptive Biotechnologies notifications

Quantus Signal · live data · not investment advice · Privacy Policy